Is Bright Minds Stock a Good Investment?
Bright Minds Investment Advice | DRUG |
- Examine Bright Minds' financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Bright Minds' leadership team and their track record. Good management can help Bright Minds navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact Bright Minds' business and its evolving consumer preferences.
- Compare Bright Minds' performance and market position to its competitors. Analyze how Bright Minds is positioned in terms of product offerings, innovation, and market share.
- Check if Bright Minds pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Bright Minds' stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Bright Minds Biosciences stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Bright Minds Biosciences is a good investment.
Sell | Buy |
Cautious Hold
Market Performance | Very Weak | Details | |
Volatility | Somewhat reliable | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Average | Details | |
Economic Sensitivity | Almost mirrors the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Bright Minds Stock
Researching Bright Minds' stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 27.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.45. Bright Minds Biosciences had not issued any dividends in recent years. The entity had 1:5 split on the 14th of July 2023.
To determine if Bright Minds is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Bright Minds' research are outlined below:
| Bright Minds generated a negative expected return over the last 90 days | |
| Bright Minds has high historical volatility and very poor performance | |
| Bright Minds has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (2.8 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Bright Minds Biosciences currently holds about 8.64 M in cash with (1.85 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.71. | |
| Bright Minds has a poor financial position based on the latest SEC disclosures | |
| Roughly 27.0% of the company shares are held by company insiders |
Bright Minds uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Bright Minds Biosciences. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Bright Minds' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 6th of February 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Bright Minds' market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 226.37 M.Basic technical analysis of Bright Stock
As of the 27th of March, Bright Minds shows the Downside Deviation of 3.86, mean deviation of 3.41, and Risk Adjusted Performance of 0.0197. Bright Minds Biosciences technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Bright Minds Biosciences information ratio, as well as the relationship between the potential upside and kurtosis to decide if Bright Minds Biosciences is priced correctly, providing market reflects its regular price of 35.57 per share. Given that Bright Minds has jensen alpha of 0.0588, we suggest you to validate Bright Minds Biosciences's prevailing market performance to make sure the company can sustain itself at a future point.Bright Minds' insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Bright Minds insiders, such as employees or executives, is commonly permitted as long as it does not rely on Bright Minds' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Bright Minds insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Cormorant Asset Management, Lp over three months ago Acquisition by Cormorant Asset Management, Lp of 184331 shares of Bright Minds at 21.7 subject to Rule 16b-3 | ||
Cormorant Asset Management, Lp over three months ago Insider Trading |
Bright Minds' Outstanding Corporate Bonds
Bright Minds issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Bright Minds Biosciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Bright bonds can be classified according to their maturity, which is the date when Bright Minds Biosciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Understand Bright Minds' technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Bright Minds' various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0197 | |||
| Market Risk Adjusted Performance | 0.0641 | |||
| Mean Deviation | 3.41 | |||
| Semi Deviation | 3.71 | |||
| Downside Deviation | 3.86 | |||
| Coefficient Of Variation | 7360.03 | |||
| Standard Deviation | 4.88 | |||
| Variance | 23.78 | |||
| Information Ratio | 0.012 | |||
| Jensen Alpha | 0.0588 | |||
| Total Risk Alpha | 0.0704 | |||
| Sortino Ratio | 0.0152 | |||
| Treynor Ratio | 0.0541 | |||
| Maximum Drawdown | 18.07 | |||
| Value At Risk | (6.41) | |||
| Potential Upside | 9.88 | |||
| Downside Variance | 14.88 | |||
| Semi Variance | 13.75 | |||
| Expected Short fall | (4.97) | |||
| Skewness | 0.8208 | |||
| Kurtosis | 0.789 |
| Risk Adjusted Performance | 0.0197 | |||
| Market Risk Adjusted Performance | 0.0641 | |||
| Mean Deviation | 3.41 | |||
| Semi Deviation | 3.71 | |||
| Downside Deviation | 3.86 | |||
| Coefficient Of Variation | 7360.03 | |||
| Standard Deviation | 4.88 | |||
| Variance | 23.78 | |||
| Information Ratio | 0.012 | |||
| Jensen Alpha | 0.0588 | |||
| Total Risk Alpha | 0.0704 | |||
| Sortino Ratio | 0.0152 | |||
| Treynor Ratio | 0.0541 | |||
| Maximum Drawdown | 18.07 | |||
| Value At Risk | (6.41) | |||
| Potential Upside | 9.88 | |||
| Downside Variance | 14.88 | |||
| Semi Variance | 13.75 | |||
| Expected Short fall | (4.97) | |||
| Skewness | 0.8208 | |||
| Kurtosis | 0.789 |
Consider Bright Minds' intraday indicators
Bright Minds intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Bright Minds stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 3377.95 | |||
| Daily Balance Of Power | (0.18) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 36.74 | |||
| Day Typical Price | 36.35 | |||
| Price Action Indicator | (1.37) | |||
| Period Momentum Indicator | (0.42) | |||
| Relative Strength Index | 50.04 |
Bright Stock media impact
Far too much social signal, news, headlines, and media speculation about Bright Minds that are available to investors today. That information is available publicly through Bright media outlets and privately through word of mouth or via Bright internal channels. However, regardless of the origin, that massive amount of Bright data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Bright Minds news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Bright Minds relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Bright Minds' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Bright Minds alpha.
Bright Minds Corporate Management
| FCCP MD | Chief Officer | Profile | |
| Jan MSc | Interim Director | Profile | |
| Emer MBA | Consultant | Profile | |
| Gideon Shapiro | VP Discovery | Profile | |
| Ian McDonald | CEO, CoFounder | Profile |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Bright Minds Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bright Minds. If investors know Bright will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bright Minds listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Bright Minds Biosciences is measured differently than its book value, which is the value of Bright that is recorded on the company's balance sheet. Investors also form their own opinion of Bright Minds' value that differs from its market value or its book value, called intrinsic value, which is Bright Minds' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bright Minds' market value can be influenced by many factors that don't directly affect Bright Minds' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Bright Minds' value and its price, as these two are different measures arrived at by various means. Investors typically determine if Bright Minds is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bright Minds' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.